Jury Rules Against J&J Subsidiary in Risperdal TrialJury Rules Against J&J Subsidiary in Risperdal TrialJurors have ruled against a Johnson & Johnson subsidiary in Arkansas' billion-dollar lawsuit over the antipsychotic drug Risperdal.Associated PressAssociated Press
Trial Begins Over J&J Subsidiary’s Anti-Psychotic DrugTrial Begins Over J&J Subsidiary’s Anti-Psychotic DrugAn attorney for the state of Arkansas has asked jurors to hold a Johnson & Johnson subsidiary financially liable for allegedly concealing risks associated with its anti-psychotic drug Risperdal.Associated PressAssociated Press